3/8/23 16:05 | 3/6/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.m | -630 | 9.55 | 0 | -66 | -96 | 3 | D | | | | | | | | | | | | | | |
3/7/23 16:14 | 3/4/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.dm | 0 | 0.00 | 0 | 66 | 999% | 69 | D | | | | | | | | | | | | | | |
3/2/23 07:38 | 2/28/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 63 | | 3 | D | | | | | | | | | | | | | | |
3/2/23 07:38 | 2/28/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -627 | 9.89 | 0 | -63 | -96 | 3 | D | | | | | | | | | | | | | | |
7/29/22 07:02 | 7/28/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S | -526 | 9.04 | 0 | -58 | -95 | 3 | D | | | | | | | | | | | | | | |
3/8/22 16:13 | 3/4/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.dm | 0 | 0.00 | 0 | 72 | | 61 | D | | | | | | | | | | | | | | |
3/8/22 16:13 | 3/4/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.dm | -241 | 7.45 | 0 | -32 | -35 | 61 | D | | | | | | | | | | | | | | |
3/2/22 07:54 | 2/28/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 18 | 625 | 21 | D | | | | | | | | | | | | | | |
3/2/22 07:54 | 2/28/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -53 | 8.14 | 0 | -6 | -23 | 21 | D | | | | | | | | | | | | | | |
2/10/22 16:13 | 2/9/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 13 | | 9 | D | | | | | | | | | | | | | | |
2/10/22 16:13 | 2/9/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -55 | 9.06 | 0 | -6 | -39 | 9 | D | | | | | | | | | | | | | | |